Forte Biosciences, Inc. (FBRX)

$7.33 4.12% $0.29 Healthcare

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

$10.70M

Dr. Paul A. Wagner Ph.D.

6.00

Dallas, TX

Apr 12, 2017

-0.42

$-17.25

3.19

9.45

-535,716.67%

-0.81

-0.00

0.91

3,446.84

9.14

-100.39%

-99.44%

Similar stocks (13)

Edgewise Therapeutics, Inc.

EWTX

$16.79 -10.83%
Neutral

Erasca, Inc.

ERAS

$2.78 -6.57%
Uptrend

Celcuity Inc.

CELC

$15.18 1.34%
Downtrend

C4 Therapeutics, Inc.

CCCC

$6.36 -1.17%
Neutral

Rezolute, Inc.

RZLT

$5.17 -1.53%
Uptrend

Werewolf Therapeutics, Inc.

HOWL

$2.14 -8.55%
Downtrend

ZIVO Bioscience, Inc.

ZIVO

$12.00 1.69%
Uptrend

Tempest Therapeutics, Inc.

TPST

$1.35 -6.83%
Downtrend

Indaptus Therapeutics, Inc.

INDP

$1.50 -3.85%
Downtrend

ABVC BioPharma, Inc.

ABVC

$0.68 -1.99%
Downtrend

Pasithea Therapeutics Corp.

KTTA

$3.90 0.78%
Downtrend

Comera Life Sciences Holdings, Inc.

CMRA

$0.02 0.00%
Downtrend

Better Therapeutics, Inc.

BTTX

$0.00 0.00%
Downtrend

ETF Exposure (9)

Fidelity Nasdaq Composite Index ETF

ONEQ

0%

$69.35 -0.62%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.45 0.51%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.44 0.51%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.44 0.51%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$134.52 1.86%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.94 0.72%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$277.53 0.11%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.92 0.72%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$178.21 0.46%
Uptrend